Muhammad Wasif Saif
About
In The Last Decade
Muhammad Wasif Saif
399 papers receiving 7.7k citations
Peers
Comparison fields: 5 of 149
- Oncology 4.6k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 1.4k
- Surgery 1.2k
- Epidemiology 995
Countries citing papers authored by Muhammad Wasif Saif
This map shows the geographic impact of Muhammad Wasif Saif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Wasif Saif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Wasif Saif more than expected).
Fields of papers citing papers by Muhammad Wasif Saif
This network shows the impact of papers produced by Muhammad Wasif Saif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Wasif Saif. The network helps show where Muhammad Wasif Saif may publish in the future.
Co-authorship network of co-authors of Muhammad Wasif Saif
This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Wasif Saif. A scholar is included among the top collaborators of Muhammad Wasif Saif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Wasif Saif. Muhammad Wasif Saif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | 6 | |
| 5 | 61 | |
| 6 | Gemcitabine-induced pulmonary toxicity. | 24 |
| 7 | Diabetes and pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. | 11 |
| 8 | Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers | 1 |
| 9 | Pancreatic cancer: translating lessons from mouse models. | 1 |
| 10 | Skeletal metastases in pancreatic cancer: a retrospective study and review of the literature. | 41 |
| 11 | Management of Bisphosphonate-Related Osteonecrosis of the Jaw | 1 |
| 12 | 44 | |
| 13 | 8 | |
| 14 | Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008. | 4 |
| 15 | New Developments in the Treatment of Pancreatic Cancer | 17 |
| 16 | Is there a Role for Herbal Medicine in theTreatment of Pancreatic Cancer | 5 |
| 17 | 20 | |
| 18 | Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future. | 36 |
| 19 | 32 | |
| 20 | 33 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.